Billionaire entrepreneur Elon Musk, founder of Neuralink, reported the successful implantation of the brain-chip startup’s device in a human, with promising initial results in neuron spike detection. Named “Telepathy,” the first Neuralink product aims to enable control of devices through thought, benefiting individuals with limb disabilities. While Musk has a history of ambitious promises, this achievement is a significant step toward realizing the company’s goals. The wireless brain-computer interface, part of the Prime study, aims to evaluate safety and functionality for people with quadriplegia. Despite past regulatory fines, Neuralink’s progress is closely watched in the brain-computer interface community.
